Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Spring;7(2):87-92.

Melatonin effects in methylphenidate treated children with attention deficit hyperactivity disorder: a randomized double blind clinical trial

Affiliations

Melatonin effects in methylphenidate treated children with attention deficit hyperactivity disorder: a randomized double blind clinical trial

Mohammad Reza Mohammadi et al. Iran J Psychiatry. 2012 Spring.

Abstract

Objective: The aim of this study was to determine melatonin effects on sleep patterns, symptoms of hyperactivity and attention deficiency in children with attention-deficit hyperactivity disorder (ADHD).

Methods: Children with age range of 7-12 years who had a combined form of ADHD were randomly divided in to 2 groups according to gender blocks. One group took melatonin (3 or 6mg) combined with methylphenidate (Ritalin) (1mg/kg), and the other group took placebo combined with methylphenidate (1mg/kg). ADHD rating scale and sleep patterns questionnaires were completed. Research hypotheses were assessed at the baseline, the second, fourth and eighth weeks after the treatment.

Results: The mean sleep latency and total sleep disturbance scores were reduced in melatonin group, while the scores increased in the placebo group (p≥0.05). Data analysis, using ANOVA with repeated measures, did not show any statistically significant differences between the two groups in ADHD scores.

Conclusion: Administration of melatonin along with methylphenidate can partially improve symptoms of sleep disturbance. However, it does not seem to reduce attention deficiency and hyperactivity behavior of children with ADHD.

Keywords: Attention deficit disorder with hyperactivity Disorder; Child; Melatonin; Methylphenidate; Sleep.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Mean attention deficiency scores of two trial groups based on ADHD (attention-deficit hyperactivity disorder) rating scale at baseline, 2, 4 and 8 weeks after the treatment using ANOVA with repeated measures
Figure 2
Figure 2
Mean hyperactivity scores of two trial groups based on ADHD rating scale at baseline, 2, 4 and 8 weeks after the treatment using ANOVA with repeated measures.
Figure 3
Figure 3
Mean total sleep duration (hour) of two trial group on SDSC sleep questionnaire at baseline, 2, 4 and 8 weeks after the treatment using ANOVA with repeated measures.
Figure 4
Figure 4
Mean total sleep latency (minute) of two trial groups on SDSC sleep questionnaire at baseline, 2, 4 and 8 weeks after the treatment using ANOVA with repeated measures.
Figure 5
Figure 5
Mean total sleep score of two trial groups on SDSC sleep questionnaire at baseline, 2, 4 and 8 weeks after the treatment using ANOVA with repeated measures.

References

    1. Corkum P, Davidson F, Macpherson M. A framework for the assessment and treatment of sleep problems in children with attention-deficit/hyperactivity disorder. Pediatr Clin North Am. 2011;58:667–683. - PubMed
    1. Weiss MD, Salpekar J. Sleep problems in the child with attention-deficit hyperactivity disorder: defining aetiology and appropriate treatments. CNS Drugs. 2010;24:811–828. - PubMed
    1. Owens JA. Sleep disorders and attention-deficit/hyperactivity disorder. Curr Psychiatry Rep. 2008;10:439–444. - PubMed
    1. Stein MA. Unravelling sleep problems in treated and untreated children with ADHD. J Child Adolesc Psychopharmacol. 1999;9:157–168. - PubMed
    1. Mohammadi MR, Kashani L, Akhondzadeh S, Izadian ES, Ohadinia S. Efficacy of theophylline compared to methylphenidate for the treatment of attention-deficit hyperactivity disorder in children and adolescents: a pilot double-blind randomized trial. J Clin Pharm Ther. 2004;29:139–144. - PubMed

LinkOut - more resources